EASL declares ongoing commitment to fighting hepatitis
Every year, the World Hepatitis Day brings the world together to focus on the theme of raising awareness about the global burden of viral hepatitis (inflammation of the liver), and to advocate…
Explore the Viral Hepatitis track at Digital ILC 2020
The curative potential of direct-acting antivirals (DAAs) for hepatitis C virus (HCV) infection have transformed hepatology in recent years. However, the challenge of identifying more people living with HCV remains, and further…
PREDICT Study uncovers three clinical courses in acutely decompensated cirrhosis with distinct pathophysiology
Researchers at EF Clif identify three different clinical courses for the first time, in patients with acute decompensated cirrhosis without acute-on-chronic liver failure (ACLF). July 14, 2020 – A clinical study led…
Journal of Hepatology ranking climbs, remaining best journal on liver disease
ClarivateTM Analytics released the 2020 update of its Journal Citation Reports©, including the much anticipated 2019 impact factor. EASL’s flagship monthly journal, the Journal of Hepatology, achieved unprecedented results with a 2019…
Blood tests can predict the risk of liver cirrhosis
Repeated measurements of the biomarker FIB-4 in the blood every few years can predict the risk of developing severe liver disease, according to a new study from Karolinska Institutet in Sweden published…
Digital ILC 2020 – Meet the experts
This is the ideal opportunity for you to learn from some of the biggest names in hepatology and meet them in an engaging & interactive setting!
Maternal obesity increases the chance of liver cancer in offspring for generations
Scientists have identified a microRNA in obese mouse mothers that may increase the odds of liver cancer in their offspring throughout multiple generations, report scientists in the Journal of Hepatology. Amsterdam, June…